发明申请
- 专利标题： Dosage form comprising self-destructive membrane
- 专利标题（中）： 包含自毁膜的剂型
-
申请号： US10957357申请日： 2004-10-01
-
公开(公告)号： US20050048120A1公开(公告)日： 2005-03-03
- 发明人: David Edgren , Robert Skluzacek , Shu Li , Patrick Wong , Paul Magruder
- 申请人： David Edgren , Robert Skluzacek , Shu Li , Patrick Wong , Paul Magruder
- 主分类号： A61K9/00
- IPC分类号： A61K9/00 ; A61K9/26 ; A61K38/01 ; A61K9/24 ; A61K38/00
摘要：
A sustained release dosage form is disclosed, which dosage form comprises an interior lipophilic membrane, and an exterior hydrophilic membrane comprising a peptide, that surround a composition comprising a drug. The dosage form at the end of its drug delivery period self-ruptures for enhancing its exit from the environment of use.